Updated: Jun 23, 2022
Helping to Make the discoveries that defeat Rhabdomyosarcoma and sarcoma cancer
The 8 June event, also offered an exclusive opportunity to view the new ‘Cancer Revolution: Science, innovation and hope’ exhibition, and meet some of our scientists who were involved.
The Discovery Club
Lynn and Lynn Lucas of the Chris Trust are members of the ICR Discovery Club since 2012 Discovery Club is a special group of visionary supporters who help us to make the discoveries that defeat cancer.
ICR - Our high-value giving club provides its members with personal access to the science behind our discoveries. Through special events and updates, it is an opportunity to speak directly with the people who are working towards better outcomes for cancer patients and learn more about key areas of the ICR’s work.Cancer has no boundaries, it's taking our children's life's away.
Lynn Said, Since our son Christopher was taken from us 22 years ago, we have prioritised our lives to fund childhood cancer. What happened to us could happen to any family. We are always looking for support from fundraisers to help us achieve our mission, sadly we do not receive any grants or lottery funding to help us with cancer research. We are so disappointed to learn that a lot of organisations won't support medical research? Yes we receive many kind words, but unfortunately, they don't save life's.
Our mission is to make the discoveries that defeat cancer.
Your donation will help us invest in the best people, programmes, and cutting-edge buildings and equipment.
Meet our Team
Professor Janet Shipley. Head of Division and Team
Professor Janet Shipley is investigating ways to improve the treatment of patients with sarcomas that have a poor outcome. She is the Head of the Division of Molecular Pathology.
Originally from Newcastle upon Tyne, Janet Shipley obtained a BSc (Hons) in Biology from Southampton University and a PhD from the University of London.
She has previously worked in the DNA Repair Group at the Paediatric Research Unit at Guy's Hospital in London, the Genetics Division of Harvard at Children's Hospital in Boston, USA and the Imperial Cancer Research Fund UK (which became the London Research Institute and is now part of The Francis Crick Institute).
Professor Shipley moved to The Institute of Cancer Research, London, to establish a laboratory characterising genetic rearrangements in tumours and was awarded tenure in 1996 and a readership in 2003. She has authored more than 160 peer-reviewed manuscripts.
Her current research is focused on identifying molecular markers of high-risk in young onset sarcomas and understanding associated molecular mechanisms in order to derive novel treatments for these patients.
Research advances are taken forward to potential benefit of patients through her membership of the National Cancer Research Institute (NCRI) Clinical Studies Young Onset Sarcoma Subgroup (YOSS) and her Chairmanship of the Biological Committee for the European paediatric Soft tissue sarcoma Study Group (EpSSG). She also sits on the Research Advisory Board of the charity Sarcoma UK and the editorial board of a number of journals.
Institute of Cancer Research, Surrey
Dr Joanna Selfe Senior Scientific Officer
I am a Senior Scientific Officer and am involved in several projects looking at rhabdomyosarcoma. These involve trying to improve the prognostication of rhabdomyosarcoma as well as identifying new drug
targets and approaches to treating rhabdomyosarcoma to achieve better outcomes while sparing children unnecessary treatment and therefore side effects that can affect them in later life.
Great North Bike Ride 28th August 2022
Chris Lucas Trust
Charity Number 1085775